Use of metrizamide computerized tomographic cisternography in the evaluation of patients with malignant glioma for immunotherapy

E. A. Neuwelt, J. T. Diehl, S. A. Hill, K. R. Maravilla

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The communication between the subarachnoid space and the surgically created tumor cavity in glioma patients was evaluated by metrizamide cisternography. It was necessary to know the presence or absence of such a communication to determine the route of administration of autologous lymphocytes as a form of immunotherapy. The contrast injections were made either into the spinal subarachnoid space or directly into the tumor cavity. The presence of communication was demonstrated and followed by computerized tomographic (CT) scanning. The results were also corroborated by comparing the white cell counts in the fluid from the tumor cavity and the spinal subarachnoid space 24 hours after autologous lymphoid cell infusion. In only two of seven patients was a communication present. In the five patients without a communication, the blocks were at the tentorial hiatus (one patient), due to a nonpatent subarachnoid space over the cerebral convexity (two patients), and the result of adhesions at the pial margin of the tumor cavity (three patients). In addition, certain limitations in the use of computerized tomography in the evaluation of glioma patients are demonstrated. These problems include the effects of steroids on tumor size, the poor correlation between 'enhancement' on CT scan and tumor recurrence, and the difficulty of differentiating metrizamide and hemorrhage by CT scan in the immediate postoperative period.

Original languageEnglish (US)
Pages (from-to)576-582
Number of pages7
JournalNeurosurgery
Volume5
Issue number5
DOIs
StatePublished - 1979
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Use of metrizamide computerized tomographic cisternography in the evaluation of patients with malignant glioma for immunotherapy'. Together they form a unique fingerprint.

Cite this